Ovarian cancer-derived IL-4 promotes immunotherapy resistance.
Mollaoglu G, Tepper A, Falcomatà C, Potak HT, Pia L, Amabile A, Mateus-Tique J, Rabinovich N, Park MD, LaMarche NM, Brody R, Browning L, Lin JR, Zamarin D, Sorger PK, Santagata S, Merad M, Baccarini A, Brown BD.
Mollaoglu G, et al. Among authors: brody r.
Cell. 2024 Dec 26;187(26):7492-7510.e22. doi: 10.1016/j.cell.2024.10.006. Epub 2024 Oct 30.
Cell. 2024.
PMID: 39481380